Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2
International Journal of Cancer, 05/18/09
Salas S et al. - The data suggest that HSD17B10, RPL8, IFITM2, and IFITM3 genes are involved in the response to the chemotherapy and that HSD17B10 may be a therapeutic target. RPL8 and IFITM2 may be useful in the assessment at diagnosis and for stratifying patients taking part in randomized trials.
Related Articles
The role of interferons in the treatment of osteosarcoma
Pediatric Blood & Cancer, 11/12/09
Relevance Score: 88%
Reconstruction Using a Frozen Bone Method for Osteosarcoma of the Talus. A Case Report and Review of the Literature
Anticancer Research, 11/11/09
Relevance Score: 88%
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
British Journal of Cancer, 11/06/09
Relevance Score: 88%
Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience
Acta Oncologica, 10/26/09
Relevance Score: 88%
Tumoral Calcinosis Mimicking Recurrent Osteosarcoma
Radiology Case Reports, 10/23/09
Relevance Score: 88%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
The expression of Gli3, regulated by HOXD13, may play a role in idiopathic congenital talipes equinovarus
BMC Musculoskeletal Disorders, 11/23/09
Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis
Bone , 11/23/09
Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis
The Spine Journal, 11/23/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/25/09
The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)
Cancer, 11/25/09
Orthopaedic Deformities Associated With Lumbosacral Spinal Lipomas
Journal of Pediatric Orthopaedics , 11/25/09
Article Search
Sponsor


See Latest Articles


